STOCK TITAN

If You Invested in Aeglea BioTherapeutics Inc (AGLE)

Looking for the current price? See the AGLE quote & overview
$1,000 invested 1 Year Ago
N/A
Trading since 2016-04-07
$1,000 invested 5 Years Ago
$146
-85.4% price return -57.7% CAGR
-85.4% with dividends reinvested
Bought on Nov 1, 2021 at $190.00 split-adjusted

What $1,000 or $10,000 in AGLE Would Be Worth Now

Real historical value by amount invested and how long ago
If you invested 1 year ago 5 years ago 10 years ago Since Apr 7, 2016
$1,000 — $146 -85% $206 -79% $113 -89%
$10,000 — $1,456 -85% $2,064 -79% $1,132 -89%

Based on real historical closing prices adjusted for stock splits, without dividends, through 2024-01-29. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.

Custom Calculation

Choose your own date and amount for AGLE

$1,000 Investment Over Time

AGLE vs S&P 500

Year-by-Year Returns

AGLE annual performance
Year Start Price End Price Annual Return Cumulative
2016 $244.25 $108.75 -55.5% -55.5%
2017 $108.75 $135.25 +24.4% -44.6%
2018 $135.25 $187.25 +38.4% -23.3%
2019 $187.25 $191.00 +2.0% -21.8%
2020 $191.00 $196.75 +3.0% -19.4%
2021 $196.75 $118.75 -39.6% -51.4%
2022 $118.75 $11.25 -90.5% -95.4%
2023 $11.25 $21.52 +91.3% -91.2%
2024 $21.52 $27.66 +28.5% -88.7%

About Aeglea BioTherapeutics Inc

Current Price
$27.66
View full AGLE overview

Frequently Asked Questions

Aeglea BioTherapeutics Inc investment returns

How much would $1,000 invested in Aeglea BioTherapeutics Inc be worth today?

If you invested $1,000 in Aeglea BioTherapeutics Inc (AGLE) 10 years ago on 2016-10-31, your investment would be worth $206 as of 2024-01-29, a -79.4% price return without dividends, growing at a compounded rate of -19.6% per year (CAGR).

Has Aeglea BioTherapeutics Inc outperformed the S&P 500?

Over the past 10 years, AGLE returned -79.4% compared to +262.1% for the S&P 500, underperforming the benchmark by 341.4 percentage points.

What is Aeglea BioTherapeutics Inc's average annual return?

The compound annual growth rate (CAGR) of AGLE’s share price over the past 10 years is -19.6%, without dividends. Individual years vary a great deal, and AGLE’s best recent full year was 2023 (+91.3%) while the worst was 2022 (-90.5%).

For informational and educational purposes only, not investment advice.